F
Fox Darrell E
Researcher at Pfizer
Publications - 29
Citations - 201
Fox Darrell E is an academic researcher from Pfizer. The author has contributed to research in topics: Alkyl & Alpha-1A adrenergic receptor. The author has an hindex of 7, co-authored 29 publications receiving 194 citations.
Papers
More filters
Journal ArticleDOI
Synthesis of (S,S)- and (R,R)-2-alkyl-2,5-diazabicyclo[2.2.1]heptanes
Braish Tamim F,Fox Darrell E +1 more
TL;DR: La synthese du (5S,S) methyl-2 diaza-2,5bicyclo [2.2.1] heptane et de son enantiomere est reportee
Journal ArticleDOI
Azatetralone synthesis via regioselective grignard coupling and parham cyclization
Journal ArticleDOI
A Practical Synthesis of N-Substituted Maleimides
Braish Tamim F,Fox Darrell E +1 more
Journal ArticleDOI
Development of a Scaleable Process for the Synthesis of the A2a Agonist, UK-371,104
Stephen Challenger,Yann Dessi,Fox Darrell E,Lynsey C. Hesmondhalgh,Pierre Pascal,Alan John Pettman,Smith Julian Duncan +6 more
TL;DR: In this paper, the development and utilization of a scaleable process for the manufacture of the A2a agonist UK-371,104 (1) was described, which included a palladium-catalyzed cyanation reaction to prepare the nitrile 10, a telescoped conversion of the acid 11 to the glycosidation substrate 9, and the stereoselective coupling of 8 with 9 in a glycoidation reaction mediated by TMS triflate in 1,2-dimethoxyethane followed by conversion through to 1.
Journal ArticleDOI
New Disulfide Route to 3-(1-Piperazinyl)-1,2-benzisothiazole. Nucleus for Atypical Antipsychotic Drugs
TL;DR: A one-step commercial process for the preparation of 3-(1-piperazinyl)-1,2-benzisothiazole hydrochloride, a key intermediate for the syntheses of some new, "atypical antipsychotic" drugs, was described in this article.